JDOC vs. BBH

Last updated Jun 4, 2026

JDOC (Jpmorgan Healthcare Leaders ETF) and BBH (VanEck Vectors Biotech ETF) are both Health & Biotech Equities funds. JDOC is actively managed, while BBH is passively managed. Over the past year, JDOC returned 12.36% vs 23.92% for BBH. A 0.78 correlation means they provide meaningful diversification when combined. JDOC charges 0.65%/yr vs 0.35%/yr for BBH.

Performance

JDOC vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jpmorgan Healthcare Leaders ETF (JDOC) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JDOC achieves a -4.49% return, which is significantly lower than BBH's -1.85% return.

JDOC

• 1D: 0.50%
• 1M: 0.16%
• YTD: -4.49%
• 6M: -4.39%
• 1Y: 12.36%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BBH

• 1D: 2.22%
• 1M: 0.09%
• YTD: -1.85%
• 6M: -5.32%
• 1Y: 23.92%
• 3Y*: 6.14%
• 5Y*: 0.31%
• 10Y*: 5.75%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JDOC vs. BBH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
JDOC Jpmorgan Healthcare Leaders ETF	-4.49%	15.36%	-1.04%	10.71%
BBH VanEck Vectors Biotech ETF	-1.85%	21.18%	-4.29%	11.77%

Correlation

The correlation between JDOC and BBH is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.81
Correlation (All Time) Calculated using the full available price history since Nov 3, 2023	0.78

The correlation between JDOC and BBH has been stable across timeframes, ranging from 0.78 to 0.81 - a consistent structural relationship.

JDOC vs. BBH - Sectors Allocation Comparison

Sectors	JDOC	BBH
Healthcare	100.0%	99.9%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

JDOC vs. BBH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JDOC

JDOC Risk / Return Rank: 26
JDOC Sharpe Ratio Rank: 25
JDOC Sortino Ratio Rank: 26
JDOC Omega Ratio Rank: 24
JDOC Calmar Ratio Rank: 27
JDOC Martin Ratio Rank: 25

BBH

BBH Risk / Return Rank: 37
BBH Sharpe Ratio Rank: 35
BBH Sortino Ratio Rank: 35
BBH Omega Ratio Rank: 33
BBH Calmar Ratio Rank: 46
BBH Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JDOC vs. BBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jpmorgan Healthcare Leaders ETF (JDOC) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JDOC	BBH	Difference
Sharpe ratio: Return per unit of total volatility	0.88	1.26	-0.38
Sortino ratio: Return per unit of downside risk	1.38	1.89	-0.50
Omega ratio: Gain probability vs. loss probability	1.16	1.22	-0.06
Calmar ratio: Return relative to maximum drawdown	1.28	2.28	-1.00
Martin ratio: Return relative to average drawdown	3.34	5.81	-2.47
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JDOC vs. BBH - Sharpe Ratio Comparison

The current JDOC Sharpe Ratio is 0.88, which is lower than the BBH Sharpe Ratio of 1.26. The chart below compares the historical Sharpe Ratios of JDOC and BBH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JDOC	BBH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.88	1.26	-0.38
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.01	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.26	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	0.38	+0.15

Drawdowns

JDOC vs. BBH - Drawdown Comparison

The maximum JDOC drawdown since its inception was -20.87%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for JDOC and BBH.

Drawdown Indicators

	JDOC	BBH	Difference
Max Drawdown Largest peak-to-trough decline	-20.87%	-72.70%	+51.83%
Max Drawdown (1Y) Largest decline over 1 year	-9.68%	-10.55%	+0.87%
Max Drawdown (3Y) Largest decline over 3 years	—	-22.74%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-39.86%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-39.86%	—
Current Drawdown Current decline from peak	-7.47%	-13.81%	+6.34%
Average Drawdown Average peak-to-trough decline	-6.98%	-20.75%	+13.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.71%	4.13%	-0.42%

Volatility

JDOC vs. BBH - Volatility Comparison

The current volatility for Jpmorgan Healthcare Leaders ETF (JDOC) is 3.97%, while VanEck Vectors Biotech ETF (BBH) has a volatility of 6.06%. This indicates that JDOC experiences smaller price fluctuations and is considered to be less risky than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JDOC	BBH	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.97%	6.06%	-2.09%
Volatility (6M) Calculated over the trailing 6-month period	9.97%	14.28%	-4.31%
Volatility (1Y) Calculated over the trailing 1-year period	14.08%	19.02%	-4.94%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.32%	21.50%	-7.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	14.32%	22.17%	-7.85%

JDOC vs. BBH - Expense Ratio Comparison

JDOC has a 0.65% expense ratio, which is higher than BBH's 0.35% expense ratio.

Dividends

JDOC vs. BBH - Dividend Comparison

JDOC's dividend yield for the trailing twelve months is around 0.93%, more than BBH's 0.51% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBH VanEck Vectors Biotech ETF	0.51%	0.51%	0.80%	0.43%	0.47%	0.21%	0.36%	0.34%	0.50%	0.55%	0.30%	0.27%
JDOC Jpmorgan Healthcare Leaders ETF	0.93%	0.89%	5.57%	0.15%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both JDOC and BBH in my portfolio?

JDOC and BBH have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JDOC or BBH?

BBH has higher volatility (6.06%) compared to JDOC (3.97%). In terms of maximum drawdown, JDOC dropped -20.87% vs BBH's -72.70%.

Which ETF is better, JDOC or BBH?

On 1-year performance, BBH leads with 23.92% vs 12.36% for JDOC. On fees, BBH is cheaper at 0.35% per year. On volatility, JDOC has been the lower-risk option at 3.97%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, JDOC or BBH?

Over the 1-year period, BBH has performed better with a 23.92% return vs 12.36%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, JDOC or BBH?

BBH is cheaper with a 0.35% expense ratio, compared with 0.65% for JDOC.

Which ETF pays a higher dividend yield, JDOC or BBH?

JDOC has the higher dividend yield at 0.93%, compared with 0.51% for BBH.

What is the main difference between JDOC and BBH?

They also come from different issuers: JPMorgan and VanEck. Their fees differ too: 0.65% for JDOC and 0.35% for BBH.

Which has better risk-adjusted returns?

BBH currently has the higher Sharpe Ratio (1.26 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.